Clonal analysis of bilateral breast cancer

Clinical Cancer Research

Volumn 2, Issue 4, 1996, Pages 743-748

  Shibata, Atsuko ^a,b   Tsai, Yvonne C ^a   Press, Michael F ^a   Henderson, Brian E ^a   Jones, Peter A ^a   Ross, Ronald K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BILATERAL CANCER; BREAST CANCER; CLINICAL ARTICLE; CLONE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; X CHROMOSOME;

ADULT; BREAST NEOPLASMS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR PROTEIN P53; X CHROMOSOME;

EID: 0029881434     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Vogelstein, B., Fearon, E. R , Hamilton, S. R., Kern, S. E., Preisinger, A C., Leppert, M., Nakamura, Y., White, R., Smits, A M. M., and Bos, J. L Genetic alterations during colorectal tumor development. N. Engl. J. Med., 319: 525-532, 1988.
2. Fialkow, P. J. Clonal origin of human tumors. Biochim. Biophys. Acta, 458: 283-321, 1976.
3. Vogelstein, B., Fearon, E. R., Hamilton, S. R., and Feinberg, A. P. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science (Washington DC), 227: 642-645, 1985.
4. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Preisinger, A. C., Willard, H F., Michelson, A M , Riggs, A. D., and Orkin, S. H Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res., 47. 4806-4813, 1987.
5. Gilliland, D. G., Blanchard, K. L., Levy, J., Perrin, S., and Bunn, F. Clonahty in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc. Natl Acad. Sci. USA, 88: 6848-6852, 1991.
6. Tilley, W. D., Marcelli, M., Wilson, J. D., and McPhaul, M. J. Characterization and expression of a cDNA encoding the human androgen receptor. Proc. Natl. Acad. Sci. USA, 86: 327-331, 1989.
7. La Spada, A R., Wilson, E. M., Lubahn, D. B., Harding, A. E., and Fischbeck, K. H. Androgen receptor gene mutations in X-linked spinal and hulbar muscular atrophy. Nature (Lond.), 352: 77-79, 1991.
8. Allen, R C., Zoghbi, H. Y., Moseley, A. B., Rosenblatt, H. M., and Belmont, J. W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am. J. Hum. Genet., 51: 1229-1239, 1992.
9. Mashal, R. D., Lester, S. C., and Sklar, J. Clonal analysis by study of X chromosome inactivation in formalin-fixed paraffin-embedded tissue. Cancer Res., 53: 4676-4679, 1993.
10. Tsai, Y. C., Simoneau, A. R., Spruck, C. H., III, Nichols, P. W., Steven, K., Buckley, J. D., and Jones, P. A. Mosaicism in human epithelium: macroscopic monoclonal patches cover the urothelium. J. Urol., 153: 1697-1700, 1995.
11. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
12. Sozzi, G., Miozzo, M., Pastorino, U., Pilotti, S., Donghi, R., Giarola, M., De Gregorio, L., Manenti, G., Radice, P., Minoletti, F., Porta, G. D., and Pierotti, M. A. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res.. 55: 135-140, 1995.
13. Zhang, S-Y., Bauer, B., Mitsunaga, S-I., Goodrow, T. L., and Klein-Szanto, A. J. P Lack of concordant p53 mutations in some paired primary and metastatic mouse squamous cell carcinomas induced by chemical carcinogenesis. Mol. Carcinog., 12: 77-81, 1995.
14. Spruck, C. H., III, Rideout, W. M., III, Olumi, A. F., Ohneseit, P. F., Yang, A. S., Tsai, Y. C., Nichols, P. W., Horn, T., Hermann, G. G., Steven, K., Ross, R. K., Yu, M. C., and Jones, P. A. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res., 53: 1162-1166, 1993.
15. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 5: 874-879, 1989.
16. Kesseler, H. J., Grier, R. N., Seidman, I., and Mcllveen, S. J. Bilateral primary breast cancer. JAMA, 236: 278-280, 1976.
17. Urban, J. A., Papachristou, D., and Taylor, J. Bilateral breast cancer biopsy of the opposite breast. Cancer (Phila.), 40: 1968-1973, 1977.
18. Bailey, M J., Royce, C., Sloane, J. P., Ford, H. T., Powles, T. J., and Gazet, J-C. Bilateral carcinoma of the breast. Br. J. Surg., 67: 514-516, 1980.
19. Lewis, T. R., Casey, J., Buerk, C. A., and Cammack, K. V. Incidence of lobular carcinoma in bilateral breast cancer. Am. J. Surg., 144: 635-638, 1982.
20. Chaudary, M. A., Millis, R. R., Hoskinst, E. O. L., Halder, M., Bulbrook, R. D., Cuzick, J., and Hayward, J. L. Bilateral primary breast cancer: a prospective study of disease incidence. Br. J. Surg., 71: 711-714, 1984.
21. Gogas, J., Markopoulos, C. H., Skandalakis, P., and Gogas, H. Bilateral breast cancer. Am. Surg., 59: 733-735, 1993.
22. Singletary, S. E., Taylor, S. H., Guinee, V. F., and Whitworth, P. W., Jr. Occurrence and prognosis of contralateral carcinoma of the breast. J. Am. Coll. Surg., 178: 390-396, 1994.
23. McCredie, J. A., Inch, W. R., and Alderson, M. Consecutive primary carcinomas of the breast. Cancer (Phila.), 35: 1472-1477, 1975.
24. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23-28, 1976.
25. Sidransky, D., Frost, P., von Eschenbach, A., Oyasu, R., Preisinger, A. C., and Vogelstein, B. Clonal origin of bladder cancer. N. Engl. J. Med., 326: 737-740, 1992.
26. Noguchi, S., Motomura, K., Inaji, H., Imaoka, S., and Koyama, H. Clonal analysis of human breast cancer by means of polymerase chain reaction. Cancer Res., 52: 6594-6597, 1992.
27. Dawson, P. J., Maloney, T., Gimotty, P., Juneau, P., Ownby, H., and Wolman, S. R. Bilateral breast cancer: one disease or two? Breast Cancer Res. Treat., 19: 233-244, 1991.
28. Noguchi, S., Motomura, K., Inaji, H., Imaoka, S., and Koyama, H. Differentiation of primary and secondary breast cancer with clonal analysis. Surgery (St. Louis). 115: 458-462, 1994.
29. Esrig, D., Spruck, C. H., Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S . Skinner, D. G., Jones, P. A., and Cote, R. J. Immunohistochemical detection of p53 nuclear protein correlates with mutations in the p53 gene, tumor grade, stage and prognosis in bladder cancer. Am. J. Pathol., 143: 1389-1397, 1993.
30. Hurlimann, J., Chaubert, P., and Benhattar, J. p53 gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Mod. Pathol., 7: 423-428, 1994.
31. Faille, A., De Cremoux, P., Extra, J. M., Linares, G., Espie, M., Bourstyn, E., De Rocquancourt, A., Giacchetti, S., Marty, M., and Calvo, F. p53 mutations and overexpression in locally advanced breast cancers. Br. J. Cancer. 69: 1145-1150, 1994.
32. Bergh, J., Norberg, T., Sjogren, S., Lindgren, A., and Holmberg, L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patient, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med. 1: 1029-1034, 1995.